BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 27342486)

  • 41. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Impact of disease status on outcomes of allogeneic hematopoietic stem cell transplantation in patients with refractory and relapsed acute myeloid leukemia].
    Zhou QL; Tang XW; Sun AN; Qiu HY; Jin ZM; Miao M; Fu ZZ; Zhao BR; Shi XL; Chen GH; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):954-8. PubMed ID: 22931663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
    Zhao Y; Zhang T; Zhao Y; Zhou J
    Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
    Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
    Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognostic value of KIT and other clonal genetic mutations in core-binding factor acute myeloid leukemia].
    Wu TM; Xue SL; Li Z; Yu JQ; Wang J; Wang BR; Wan CL; Shen XD; Qiu QC; Bao XB; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):646-653. PubMed ID: 34547870
    [No Abstract]   [Full Text] [Related]  

  • 46. Prognostic implication of molecular aberrations in cytogenetically normal acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Hsiao HH; Lin PM; Yang WC; Chang CS; Liu TC; Hsu JF; Yang MY; Lin SF
    Genet Mol Res; 2013 Nov; 12(4):5414-23. PubMed ID: 24301914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy.
    Lim SJ; Lim MJ; Raptis A; Hou JZ; Farah R; Marks SM; Im A; Dorritie K; Sehgal A; Agha M; Felgar R; Lim SH
    Am J Hematol; 2015 Aug; 90(8):715-8. PubMed ID: 26010177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical features and prognosis of childhood acute myeloid leukemia with myelodysplasia-related changes].
    Han TT; Gong XW; Zhang RR; Ruan M; Guo Y; Zhang L; Zou Y; Chen YM; Zhu XF; Yang WY
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Mar; 23(3):271-278. PubMed ID: 33691921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study.
    Heinonen K; Mrózek K; Lawrence D; Arthur DC; Pettenati MJ; Stamberg J; Qumsiyeh MB; Verma RS; MacCallum J; Schiffer CA; Bloomfield CD
    Br J Haematol; 1998 Jun; 101(3):513-20. PubMed ID: 9633896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
    Grosicki S; Holowiecki J; Kuliczkowski K; Skotnicki A; Hellmann A; Kyrcz-Krzemien S; Dmoszynska A; Sułek K; Kloczko J; Jedrzejczak WW; Warzocha K; Zdziarska B; Wierzbowska A; Pluta A; Komarnicki M; Giebel S
    Am J Hematol; 2015 Oct; 90(10):904-9. PubMed ID: 26149802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.
    Soni M; Brody J; Allen SL; Schulman P; Kolitz J; Rai K; Broome JD; Koduru PR
    Leukemia; 1996 Apr; 10(4):619-23. PubMed ID: 8618437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical Characteristics and Prognostic Influencing Factors of Adult AML Patients with MLL Rearrangement].
    Wang T; Zhao Y; Zhang QQ; Xu LR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):775-780. PubMed ID: 32552935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autologous Hematopoietic Stem Cell Transplantation for Adults With Acute Myeloid Leukemia.
    Cioch M; Jawniak D; Wach M; Mańko J; Radomska K; Borowska H; Szczepanek A; Hus M
    Transplant Proc; 2016 Jun; 48(5):1814-7. PubMed ID: 27496498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysis.
    Zhu Y; Gao Q; Du J; Hu J; Liu X; Zhang F
    Ann Hematol; 2018 Sep; 97(9):1519-1526. PubMed ID: 29946906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinic Outcome of Allogeneic Stem Cell Transplantation in 45 Patients with MDS].
    Wang LJ; Liu MJ; Zhao XL; Ding J; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):502-9. PubMed ID: 27151019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
    Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
    Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical Efficacy of Allo-HSCT on FLT3-ITD Positive AML Patients].
    Zhao H; Guo HX; Xiao F; Fan D; Liu Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1152-1156. PubMed ID: 32798390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.